EP2371361

GENZYME
Application Number
EP10184509A
Filing Date
Jul 30, 2002
Status
Revoked
Aug 10, 2024
Grant Date
Aug 7, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP2371361B1 was granted on Aug 7, 2019 by Genzyme The patent is currently Revoked.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ACCORD HEALTHCAREMay 7, 2020ADMISSIBLE
BETAPHARM ARZNEIMITTELMay 7, 2020ADMISSIBLE
SANDOZMay 7, 2020ADMISSIBLE
STADA ARZNEIMITTELMay 7, 2020ADMISSIBLE
ZENTIVAMay 7, 2020ADMISSIBLE
TEVA PHARMACEUTICAL INDUSTRIESMay 6, 2020ADMISSIBLE
GENERICS UK TRADING MYLANMay 4, 2020ADMISSIBLE

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionWO9965507
N/A
OppositionWO0002870
N/A
OppositionWO0018885
N/A
OppositionWO0028987
N/A
OppositionEP1016413
N/A
OppositionWO0045814
N/A
OppositionWO0144229
N/A
OppositionWO9411027
N/A
OppositionEP1411918
N/A
OppositionUS7897590
N/A
OppositionWO03011277
N/A
OppositionUS10209001
N/A

Access Full Citation Information

Get a free, in-depth citation report including examiner, opposition, and international search citations.

Get Free Citation Report

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.